This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hunt SA et al. (2005) ACC/AHA guidelines update for the diagnosis and management of chronic heart failure in the adult. Circulation 112: e154–e235
Dahlstöm U (2004) Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail 6: 281–287
Hartmann F et al. (2004) Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure. Circulation 110: 1780–1786
Kögler H et al.: Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+-ATPase expression. Circulation, in press
Valle R et al. (2005) B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function. J Card Fail 11: 498–503
Acknowledgements
The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The University of Göttingen, where B Pieske works, has received research funding from Roche Diagnostics, Germany.
Rights and permissions
About this article
Cite this article
Pieske, B. Can brain natriuretic peptide be used to diagnose and manage patients with diastolic heart failure?. Nat Rev Cardiol 3, 418–419 (2006). https://doi.org/10.1038/ncpcardio0606
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0606